The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received an additional bevacizumab treatment after the surgery.
Not Applicable
- Conditions
- Patients with neovascular glaucoma
- Registration Number
- JPRN-UMIN000000895
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have been previously treated with trabeculectomy. Patients who had been treated with bevacizumab within recent 2 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure levels after an additional treatment of bevacizumab following trabeculectomy.
- Secondary Outcome Measures
Name Time Method The size of filtrating bleb. The inflammation in the anterior chamber The concentrations of cytokines in the anterior chamber.